Thromboembolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty

Journal of Bone and Joint Surgery

Volumn 81, Issue 3, 1999, Pages 339-346

  Sarmiento, Augusto ^a,b   Goswami, A D K ^a,c  

^a JOINT REPLACEMENT INSTITUTE   (United States)

^b Arthr/Joint Replacement Institute   (United States)

^c 5 New Lodge   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ANTICOAGULANT THERAPY; ARTICLE; DEEP VEIN THROMBOSIS; EXERCISE; FEMALE; GENERAL ANESTHESIA; HUMAN; LEG COMPRESSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; REGIONAL ANESTHESIA; TOTAL HIP PROSTHESIS; TREATMENT PLANNING;

EID: 0033038347     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-199903000-00005     Document Type: Article

References (39)

1. Anderson, D. R.; O'Brien, B. J.; Levine, M. N.; Roberts, R.; Wells, P. S.; and Hirsh, J.: Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty. Ann. Intern. Med., 119: 1105-1112, 1993.
2. Barnhart, S.: Preventing pulmonary embolism: what you can do. J. Resp. Dis., 17: 810-819, 1996.
3. Beisaw, N. E.; Comerota, A. J.; Groth, H. E.; Merli, G. J.; Weitz, H. H.; Zimmerman, R. C.; Diserio, F. J.; and Sasahara, A. A.: Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial. J. Bone and Joint Surg., 70-A: 2-10, Jan. 1988.
4. Bergqvist, D.; Mätzsch, T.; Jendteg, S.; Lindgren, B.; and Persson, U.: The cost-effectiveness of prevention of post-operative thromboembolism. Acta Chir. Scandinavica, Supplementum 556, pp. 36-41, 1990.
5. Bergqvist, D.; Benoni, G.; Björgell, O.; Fredin, H.; Hedlundh, U.; Nicolas, S.; Nilsson, P.; and Nylander, G.: Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. New England J. Med., 335: 696-700, 1996.
6. Brinker, M. R.; Reuben, J. D.; Mull, J. R.; Cox, D. D.; Daum, W. J.; and Parker, J. R.: Comparison of general and epidural anesthesia in patients undergoing primary unilateral THR. Orthopedics, 20: 109-115, 1997.
7. Butterfield, W. J. H.; Hicks, B. H.; Ambler, A. R.; Barkhan, P.; Gollop, G.; Hall, C. M.; Hazell, J.; Heady, J. A.; O'Brien, J. R.; Pai, B. Y.; Quick, D.; Sirey, E. C.; Tulevski, V.; Vessey, M. P.; and Wyllie, J. H.: Effect of aspirin on postoperative venous thrombosis. Report of the steering committee of a trial sponsored by the Medical Research Council. Lancet, 2: 441-444, 1972.
8. Chrisman, O. D.; Snook, G. A.; Wilson, T. C.; and Short, J. Y.: Prevention of venous thromboembolism by administration of hydroxychloroquine. A preliminary report. J. Bone and Joint Surg., 58-A: 918-920, Oct. 1976.
9. Clagett, G. P.; Anderson, F. A., Jr.; Heit, J.; Levine, M. N.; and Wheeler, H. B.: Prevention of venous thromboembolism. Chest, 108 (Supplement 4): 312S-334S, 1995.
10. Colwell, C. W., Jr.; Spiro, T. E.; Trowbridge, A. A.; Morris, B. A.; Kwaan, H. C.; Blaha, J. D.; Comerota, A. J.; and Skoutakis, V. A.: Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. J. Bone and Joint Surg., 76-A: 3-14, Jan. 1994.
11. Coventry, M. B.; Nolan, D. R.; and Beckenbaugh, R. D.: "Delayed" prophylactic anticoagulation: a study of results and complications in 2,012 total hip arthroplasties. J. Bone and Joint Surg., 55-A: 1487-1492, Oct. 1973.
12. Evarts, C. M., and Alfidi, R. J.: Thromboembolism after total hip reconstruction. Failure of low doses of heparin in prevention. J. Am. Med. Assn., 225: 515-516, 1973.
13. Gallus, A. S.; Hirsh, J.; Tutle, R. J.; Trebilcock, R.; O'Brien, S. E.; Carroll, J. J.; Minden, J. H.; and Hudecki, S. M.: Small subcutaneous doses of heparin in prevention of venous thrombosis. New England J. Med., 288: 545-551, 1973.
14. Harris, W. H.; Salzman, E. W.; DeSanctis, R. W.; and Coutts, R. D.: Prevention of venous thromboembolism following total hip replacement. Warfarin vs dextran 40. J. Am. Med. Assn., 220: 1319-1322, 1972.
15. Harris, W. H.; Salzman, E. W.; Athanasoulis, C. A.; Waltman, A. C.; and DeSanctis, R. W.: Aspirin prophylaxis of venous thromboembolism after total hip replacement. New England J. Med., 297: 1246-1249, 1977.
16. Hirsh, J.: Oral anticoagulant drugs. New England J. Med., 324: 1865-1875, 1991.
17. Imperiale, T. F., and Speroff, T.: A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. J. Am. Med. Assn., 271: 1780-1785, 1994.
18. Jennings, J. J.; Harris, W. H.; and Sarmiento, A.: A clinical evaluation of aspirin prophylaxis of thromboembolic disease after total hip arthroplasty. J. Bone and Joint Surg., 58-A: 926-927, Oct. 1976.
19. Johnson, R.; Green, J. R.; and Charnley, J.: Pulmonary embolism and its prophylaxis following the Charnley total hip replacement. Clin. Orthop., 127: 123-132, 1977.
20. Jørgensen, L. N.; Wille-Jørgensen, P.; and Hauch, O.: Prophylaxis of postoperative thromboembolism with low molecular weight heparins. British J. Surg., 80: 689-704, 1993.
21. Kakkar, V. V.; Field, E. S.; Nicolaides, A. N.; Flute, P. T.; Wessler, S.; and Yin, E. T.: Low doses of heparin in prevention of deep-vein thrombosis. Lancet, 2: 669-671, 1971.
22. Kakkar, V. V.; Fok, P. J.; Murray, W. J. G.; Paes, T.; Merenstein, D.; Dodds, R.; Farrell, R.; Crellin, R. Q.; Thomas, E. N.; Morley, T. R.; and Price, A. J.: Heparin and dihydroergotamine prophylaxis against thrombo-embolism after hip arthroplasty. J. Bone and Joint Surg., 67-B(4): 538-542, 1985.
23. Leizorovicz, A.; Haugh, M. C.; Chapuis, F. R.; Samama, M. M.; and Boissel, J. P.: Low molecular weight heparin in prevention of perioperative thrombosis. BMJ: British Med. J., 305: 913-920, 1992.
24. Lieberman, J. R.; Huo, M. M.; Hanway, J.; Salvati, E. A.; Sculco, T. P.; and Sharrock, N. E.: The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. J. Bone and Joint Surg., 76-A: 341-348, March 1994.
25. Modig, J.; Hjelmstedt, A.; Sahlstedt, B.; and Maripuu, E.: Comparative influences of epidural and general anaesthesia on deep venous thrombosis and pulmonary embolism after total hip replacement. Acta Chir. Scandinavica, 147: 125-130, 1981.
26. Modig, J.; Borg, T.; Karlstrom, G.; Maripuu, E.; and Sahlstedt, B.: Thromboembolism after total hip replacement: role of epidural and general anesthesia. Anesth. and Analg., 62: 174-180, 1983.
27. Murray, D. W.; Britton, A. R.; and Bulstrode, C. J. K.: Thromboprophylaxis and death after total hip replacement. J. Bone and Joint Surg., 78-B(6): 863-870, 1996.
28. Nurmohamed, M. T.; Rosendaal, F. R.; Buller, H. R.; Dekker, E.; Hommes, D. W.; Vandenbroucke, J. P.; and Briet, E.: Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet, 340: 152-156, 1992.
29. Paiement, G. D.; Schutzer, S. F.; Wessinger, S. J.; and Harris, W. H.: Influence of prophylaxis on proximal venous thrombus formation after total hip arthroplasty. J. Arthroplasty, 7: 471-475, 1992.
30. Silvergleid, A. J.; Bernstein, R.; Burton, D. S.; Tanner, J. B.; Silverman, J. F.; and Schrier, S. L.: ASA-dipyridamole prophylaxis in elective total hip replacement. Orthopedics, 1: 19-25, 1978.
31. Stamatakis, J. D.; Kakkar, V. V.; Sagar, S.; Lawrence, D.; Nairn, D.; and Bentley, P. G.: Femoral vein thrombosis and total hip replacement. British Med. J., 2: 223-225, 1977.
32. Stamatakis, J. D.; Kakkar, V. V.; Lawrence, D.; Bentley, P. G.; Nairn, D.; and Ward, V.: Failure of aspirin to prevent postoperative deep vein thrombosis in patients undergoing total hip replacement. British Med. J., 1: 1031, 1978.
33. Stannard, J. P.; Harris, R. M.; Bucknell, A. L.; Cossi, A.; Ward, J.; and Arrington, E. D.: Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. Am. J. Orthop., 25: 127-134, 1996.
34. Turpie, A. G.; Levine, M. N.; Hirsh, J.; Carter, C. J.; Jay, R. M.; Powers, P. J.; Andrew, M.; Hull, R. D.; and Gent, M.: A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. New England J. Med., 315: 925-929, 1986.
35. Warwick, D.; Williams, M. H.; and Bannister, G. C.: Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. J. Bone and Joint Surg., 77-B(1): 6-10, 1995.
36. Weinmann, E. E., and Salzman, E. W.: Deep-vein thrombosis. New England J. Med., 331: 1630-1641, 1994.
37. Wille-Jørgensen, P.; Christensen, S. W.; Bjerg-Nielsen, A.; Stadeager, C.; and Kjær, L.: Prevention of thromboembolism following elective hip surgery. The value of regional anesthesia and graded compression stockings. Clin. Orthop., 247: 163-167, 1989.
38. Woolson, S. T., and Watt, J. M.: Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. J. Bone and Joint Surg., 73-A: 507-512, April 1991.
39. Woolson, S. T.: Intermittent pneumatic compression prophylaxis for proximal deep venous thrombosis after total hip replacement. J. Bone and Joint Surg., 78-A: 1735-1740, Nov. 1996.